Navigation

Home
Team
Companies
News & Ideas
Careers
Investor Portal
Contact Us

Address

Bold Capital Partners
225 Santa Monica Blvd.
Suite 900
Santa Monica
CA 90401

Google Maps

Contacts

Email us

Socials

LinkedIn

Recent Investments

Figure AI

Omeat

Immunis Biomedical

Immunis Biomedical

Immunis Biomedical

Elevian

- Elevian - Elevian -

Elevian develops regenerative medicines that target the root-cause of aging processes. Elevian has identified blood factors that regulate aging and stimulate the body’s natural repair and regeneration mechanisms and is developing biotherapeutics targeted at these factors.

Visit Company Website

Mark Allen CEO

Technologies

Biotechnology

Follow

Company News

View All News

Can A ‘Magic’ Protein Slow the Aging Process?

Can A ‘Magic’ Protein Slow the Aging Process?

Elevian snags $40M for stroke recovery and age-related diseases

Elevian snags $40M for stroke recovery and age-related diseases

Elevian Raises $40 Million Series A to Advance Treatments for Stroke Recovery and Age-Related Diseases

Elevian Raises $40 Million Series A to Advance Treatments for Stroke Recovery and Age-Related Diseases

Can GDF11 Address Aging, One Disease At A Time?

Can GDF11 Address Aging, One Disease At A Time?

Elevian and Insilico Enter a Research Collaboration to Discover Drugs That Target Aging

Elevian and Insilico Enter a Research Collaboration to Discover Drugs That Target Aging

The Future Of Aging? The New Drugs & Tech Working To Extend Life & Wellness

The Future Of Aging? The New Drugs & Tech Working To Extend Life & Wellness

Insilico Medicine

Next